Thursday’s Highlights at Noon: Jazz Pharmaceuticals (JAZZ), Amarin (AMRN), Sangamo Biosciences (SGMO), GW Pharma (GWPH), Whiting Petroleum Corp (WLL)

By Carrie Williams

So far Thursday, October 10, NASDAQ is up 1.9% and the S&P is up 1.84%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Jazz Pharmaceuticals (JAZZResearch Report), Amarin (AMRNResearch Report), Sangamo Biosciences (SGMOResearch Report), GW Pharma (GWPHResearch Report) and Whiting Petroleum Corp (WLLResearch Report).

Jazz Pharmaceuticals is down -9.8% in midday trading to $118.43. Shares opened today at $131.29. The company has a 52-week low of $113.52 and a 52-week high of $173.10. On the Street’s front, the average 12-month analyst price target for the stock is $165.13, marking a 25.78% potential upside from current levels. In a report issued on September 26, Oppenheimer analyst Esther Rajavelu reiterated a Buy rating on JAZZ, with a price target of $176.00, which represents a potential upside of 34% from where the stock is currently trading. Separately, on August 21, Piper Jaffray’s David Amsellem downgraded the stock to Hold and has a price target of $142.00. Over the last 3 months, the insider sentiment on Jazz Pharmaceuticals has been negative based on 61 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.

Amarin is up 5.96% in midday trading to $14.84. Shares opened today at $14.00. The company has a 52-week low of $11.78 and a 52-week high of $23.91. On the Street’s front, the average 12-month analyst price target for the stock is $34.60, marking a 147.14% potential upside from current levels. In a report issued on September 20, Cantor Fitzgerald analyst Louise Chen reiterated a Buy rating on AMRN, with a price target of $35.00, which implies an upside of 150% from current levels. In the last 30 days, insiders have sold $11.57M worth of AMRN shares. Over the last 3 months, the insider sentiment on Amarin has been positive based on 64 corporate insider transactions. This sentiment is slightly higher than the average sector sentiment of insiders.

Sangamo Biosciences is down -4.41% in midday trading to $7.80. Shares opened today at $8.16. The company has a 52-week low of $6.26 and a 52-week high of $14.87. On the Street’s front, the average 12-month analyst price target for the stock is $15.33, marking a 87.87% potential upside from current levels. In a report issued on August 26, H.C. Wainwright analyst Debjit Chattopadhyay initiated coverage with a Buy rating on SGMO and a price target of $16.00, which represents a potential upside of 96% from where the stock is currently trading. Separately, on August 12, Wedbush’s Liana Moussatos reiterated a Hold rating on the stock and has a price target of $11.00.

See today’s analyst top recommended stocks >>

GW Pharma is up 4.06% in midday trading to $115.89. Shares opened today at $111.37. The company has a 52-week low of $90.14 and a 52-week high of $196.00. On the Street’s front, the average 12-month analyst price target for the stock is $223.63, marking a 100.80% potential upside from current levels. In a report issued on September 27, Oppenheimer analyst Esther Rajavelu reiterated a Buy rating on GWPH, with a price target of $233.00, which represents a potential upside of 109% from where the stock is currently trading.

See today’s analyst top recommended stocks >>

Whiting Petroleum Corp is down -4.03% in midday trading to $6.66. Shares opened today at $6.94. The company has a 52-week low of $6.00 and a 52-week high of $44.58. On the Street’s front, the average 12-month analyst price target for the stock is $13.64, marking a 96.54% potential upside from current levels. In a report released today, Seaport Global analyst Mike Kelly downgraded WLL to Hold. Separately, on October 3, Credit Suisse’s William Featherston downgraded the stock to Sell and has a price target of $5.00.

Trending Stocks Based on Insider Activity >>